Oakstone Intensive Review of Nephrology 2024

Include: 95 videos 2 pdfs, size: 30.9 GB

Date of Original Release: November 15, 2024

Estimated Time to Complete the Activity: 51.00 hours

Learning Objectives

Upon completion of this activity, participants will be able to:

• Summarize current/recommended nephrology guidelines in clinical practice
• Explain the differential diagnosis of complex clinical presentations of patients with renal disorders
• Identify/integrate current therapeutic options for specific renal disorders
• Review and interpret up-to-date literature relevant to clinical practice
• Describe pathophysiological mechanisms as they apply to management of renal disease
• Synthesize teachings to better performance on the ABIM Nephrology certification/recertification examinations

Target Audience

The target audience for the Intensive Review of Nephrology course is clinical and academic nephrologists, internists, pediatricians, and primary care physicians/trainees preparing for ABIM nephrology certification/recertification examinations and/or seeking a comprehensive update in renal medicine and its subspecialties.

Topics:

01 Renal Physiology for the Boards – Melanie P. Hoenig, MD.mp4
02 Basic Concepts of Immunology in Autoimmune Kidney Disease – Ramon G. Bonegio, MD.mp4
03 Question and Answer Session – Faculty.mp4
04 Renal Pathology in 2024 – Part 1 – Nephritic Conditions – Helmut G. Rennke, MD.mp4
05 Renal Pathology in 2024 – Part 2 – Nephritic Syndrome – Astrid Weins, MD, PhD.mp4
06 Urine Sediment Analysis – Martina M. McGrath, MD.mp4
07 Question and Answer Session – Faculty.mp4
08 Pathogenesis, Diagnosis, and Treatment of IgA Nephropathy – Gerald B. Appel, MD.mp4
09 Metabolic Management of Kidney Stones – Gary C. Curhan, MD, ScD.mp4
10 Impact of the Race Multiplier in the Estimated GFR Equation on African American CKD Care Delivery – Winfred W. Williams, Jr., MD.mp4
11 Question and Answer Session – Faculty.mp4
12 Update on Lupus Nephritis – Gerald B. Appel, MD.mp4
13 Membranous Nephropathy – Laurence H. Beck, Jr., MD, PhD.mp4
14 Anemia Management – Update and Best Practices – Ajay K. Singh, MBBS, FRCP (UK), MBA.mp4
15 Question and Answer Session – Faculty.mp4
16 Acid-Base Disorders Part I – Anion Gap Metabolic Acidosis – Alan S.L. Yu, MB, BChir.mp4
17 Acid-Base Disorders II – Non-Gap Acidosis and Metabolic Alkalosis – Alan S.L. Yu, MB, Bchir.mp4
18 Question and Answer Session – Faculty.mp4
19 Sodium Disorders – David B. Mount, MD, FRCP(C).mp4
20 Potassium Disorders – David B. Mount, MD, FRCP(C).mp4
21 Question and Answer Session – Faculty.mp4
22 Important New Trials in Glomerular Disease – Saif A. Alenizi, MBChB, MPH.mp4
23 Genetics and Kidney Disease – Friedhelm Hildebrandt, MD.mp4
24 Update on Polycystic Kidney Disease – Cristian Riella, MD.mp4
25 Question and Answer Session – Faculty.mp4
26 Pediatric Nephrology – Michael J.G. Somers, MD.mp4
27 Genetics – How to Integrate It into Practice – Ana Onuchic-Whitford, MD.mp4
28 Vasculitis and ANCA – John L. Niles, MD.mp4
29 Question and Answer Session – Faculty.mp4
30 Why Do We Reject a Transplant – Jamil R. Azzi, MD.mp4
31 Transplant Immunosuppression for the Boards – Brittany L. Schreiber, MD.mp4
32 Question and Answer Session – Faculty.mp4
33 Immunological Assessment Pre and Post Transplant – Melissa Y. Yeung, MD and Indira Guleria, PhD.mp4
34 Early Post-Transplant Management – Anil K. Chandraker, MD.mp4
35 Question and Answer Session – Faculty.mp4
36 Evaluation of the Living Donor Candidate – Kassem Safa, MD.mp4
37 Late Loss of the Kidney Transplant – John Y. Choi, MD.mp4
38 Infections in Transplant Recipients – Sarah P. Hammond, MD.mp4
39 Monitoring Kidney Transplant Patients – Beyond Creatinine – Jamil R. Azzi, MD.mp4
40 Pre-Transplant Surgical Evaluation of Recipients – Saif A. Alenizi, MBChB, MPH.mp4
41 Question and Answer Session – Faculty.mp4
42 Poisonings and Intoxications – What a Nephrologist Needs to Know – Timothy B. Erickson, MD.mp4
43 Late Post-Transplant Medical Complications – Leonardo V. Riella, MD, PhD.mp4
44 Hemolytic Uremic Syndrome (HUS) and Thrombotic Thrombocytopenic Purpura (TTP) – Jean M. Francis, MD.mp4
45 Geriatric Nephrology – Ernest I. Mandel, MD.mp4
46 Question and Answer Session – Faculty.mp4
47 Cardio-Renal Syndrome – Finnian R. McCausland, MB BCh, MMSc, FRCPI.mp4
48 Management of Hypertension in CKD-Intensive or Standard Regimens – Richard J. Glassock, MD.mp4
49 Question and Answer Session – Faculty.mp4
50 Primary Aldosteronism – Anand Vaidya, MD, MMSc.mp4
51 Keynote – Climate Change, Global Inequities, and the Kidney – Valerie A. Luyckx, MB BCh, MSc, PhD.mp4
52 Liver and the Kidney – Andrew S. Allegretti, MD, MSc.mp4
53 Question and Answer Session – Faculty.mp4
54 Pathophysiology of Acute Kidney Injury – Joseph V. Bonventre, MD, PhD.mp4
55 Acute Kidney Injury Syndromes – Alice M. Sheridan, MD.mp4
56 ICU Nephrology and Continuous Renal Replacement Therapies – David J.R. Steele, MB BCh.mp4
57 Question and Answer Session – Faculty.mp4
58 Acute Kidney Injury in Cancer – Raad B. Chowdhury, MD, FASN.mp4
59 Dysproteinemia for the Nephrologist – Raad Chowdhury, MD, FASN.mp4
60 Therapy of Focal and Segmental Glomerulosclerosis (FSGS) Lesions in 2024 – Richard J. Glassock, MD.mp4
61 Pathophysiology and Treatment of Diabetic Kidney Disease – Gearoid M. McMahon, MB BCh.mp4
62 APOL1 and Kidney Disease – Opeyemi Olabisi, MD, PhD.mp4
63 Question and Answer Session – Faculty.mp4
64 Patient Perspective – Dialysis Dosing – Moderators – J. Kevin Tucker, MD and Diane Goodwin, RN, BSN, CNN, Dialysis Patients Daphne Rhodes and Vanessa Evans.mp4
65 Chronic Kidney Disease – Mineral and Bone Disease – David Bushinsky, MD.mp4
66 Question and Answer Session – Faculty.mp4
67 Dialysis – A Case-Based Clinical Review and Update – J. Kevin Tucker, MD.mp4
68 Pearls in Mineral and Bone Disease – David Bushinsky, MD.mp4
69 Chronic Kidney Disease Epidemiology – Gearoid M. McMahon, MB BCh.mp4
70 Question and Answer Session – Faculty.mp4
71 Introduction to Peritoneal Dialysis – Joanne M. Bargman, MD, FRCPC.mp4
72 Complications of Peritoneal Dialysis – Joanne M. Bargman, MD, FRCPC.mp4
73 Acute Kidney Injury Related to Immune Checkpoint Inhibitors – Shruti Gupta, MD, MPH.mp4
74 Question and Answer Session – Faculty.mp4
75 Mesoamerican Nephropathy – Ricardo Correa-Rotter, MD.mp4
76 Ultrasound for the Clinical Nephrologist – Adina S. Voiculescu, MD.mp4
77 Dialysis Vascular Access – Assessment and Complications – Dirk M. Hentschel, MD.mp4
78 Glomerulonephritis – Questions & Answers Session – Gerald B. Appel, MD.mp4
79 Must-Know Clinical Images in Nephrology – Ajay K. Singh, MBBS, FRCP (UK), MBA.mp4
80 Electrolytes and Acid-Base Practice for the Boards – Part 1 – Alan S.L. Yu, MB, Bchir.mp4
81 Electrolytes and Acid-Base Practice for the Boards – Part 2 – Alan S.L. Yu, MB, Bchir.mp4
82 Chronic Kidney Disease in the Community – Leveraging Resources Effectively, Lessons Learned from KDSAP – Li-Li Hsiao, MD, PhD, FACP.mp4
83 COVID-19 Vaccination in Immunocompromised Patients – Ann E. Woolley, MD.mp4
84 Update on Renovascular Disease – Joseph M. Garasic, MD.mp4
85 Pre-Transplant Surgical Evaluation of Recipients – Sayeed Malek, MD, FACS.mp4
86 Immunologic Basis of Kidney Disease – Vivek Kasinath, MD.mp4
87 Use of Checkpoint Inhibitors in Kidney Transplant Recipients – Naoka Murakami, MD, PhD.mp4
88 Interstitial Nephritis – Overview for the Boards – Julie M. Paik, MD, ScD, MPH.mp4
89 Ethics in Nephrology – Valerie Luyckx, MB BCh, MSc, PhD.mp4
90 Pregnancy and Renal Disease – Jessica Tangren, MD.mp4
91 Transplant Cases – Board Review Practice – Melissa Y. Yeung, MD and Edgar L. Milford, Jr., MD.mp4
92 Transplant Board Review – Anil K. Chandraker, MD.mp4
93 Must-Know Board Zebras – Emily Robinson, MD, MPH.mp4
94 Nephrology Board Review Practice 1 – Finnian R. McCausland, MB BCh, MMSc, FRCPI.mp4
95 Nephrology Board Review Practice 2 – Gearoid M. McMahon, MB BCh.mp4
Questions.pdf
Syllabus.pdf